Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014

作者:Offringa Martin; Davis Jonathan M*; Turner Mark A; Ward Robert; Bax Ralph; Maldonado Sam; Sinha Vikram; McCune Susan K; Zajicek Anne; Benjamin Daniel K Jr; Bucci Rechtweg Christina; Nelson Robert M
来源:Therapeutic Innovation & Regulatory Science, 2015, 49(5): 623-631.
DOI:10.1177/2168479015597730

摘要

The First Annual Neonatal Scientific Workshop focused on the needs of the neonate by addressing the basic question: what information is required to inform decision making both at the regulatory level and at the bedside? Priority therapeutic areas include neonatal lung, brain, and gastrointestinal injury, retinopathy of prematurity, sepsis, and neonatal abstinence syndrome. Scientific progress in these therapeutic areas, regulatory standards, and the acceptable design and conduct of clinical trials must be aligned. This report will review potential approaches to enhancing neonatal drug development.

  • 出版日期2015-9
  • 单位NIH